• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物失调与尿路感染史女性的其他危险因素之间的关联。

Associations between Gut Microbiota Dysbiosis and Other Risk Factors in Women with a History of Urinary Tract Infections.

机构信息

George Emil Palade University of Medicine Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.

Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.

出版信息

Nutrients. 2024 Jun 3;16(11):1753. doi: 10.3390/nu16111753.

DOI:10.3390/nu16111753
PMID:38892685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11174854/
Abstract

(1) Background: Urinary tract infections (UTIs) are among otherwise healthy women represent a problem that requires additional understanding and approaches. Evidencing the link between dysbiosis and UTIs and the associated potential risk factors could lead to therapeutic approaches with increased efficiency under the conditions of reducing the risks associated with antibiotic treatments. The purpose of this study was to evaluate dysbiosis and other potential risk factors in women with a history of urinary tract infections; (2) Methods: Fecal dysbiosis tests were performed comparatively in two groups of women. The first group in-cluded women with recurrent urinary tract infections (rUTI) who had either two or more symp-tomatic episodes of UTI in the previous six months. The second group included women with spo-radic UTIs who did not have >1 UTI during a 12-month period and who did not have another UTI in the last 12 months; (3) Results: An association was shown between intestinal dysbiosis and recurrences of urinary tract infections. Increased body weight was associated with intestinal dysbiosis. Also, the lack of knowledge regarding the risk of using antibiotics and the benefits of probiotics was associated with both dysbiosis and recurrences of urinary tract infections; (4) Conclusions: Dysbiosis can have an impact on the recurrence of urinary tract infections. The risk factors for rUTI and dysbiosis in the sphere of lifestyle are potentially controllable, broadening the perspective for new approaches and changing the paradigm in the treatment of urinary tract infections.

摘要

(1) 背景:在健康女性中,尿路感染 (UTI) 是一个需要进一步理解和处理的问题。证明肠道菌群失调与 UTI 之间的联系以及相关的潜在风险因素,可能会导致在降低抗生素治疗相关风险的情况下,提高治疗效率的治疗方法。本研究的目的是评估有尿路感染史的女性的肠道菌群失调和其他潜在风险因素;(2) 方法:对两组女性进行了粪便菌群失调测试。第一组包括复发性尿路感染 (rUTI) 患者,她们在过去六个月中有两次或两次以上有症状的 UTI 发作。第二组包括偶发性 UTI 患者,她们在 12 个月内没有 >1 次 UTI,并且在过去 12 个月内没有再次发生 UTI;(3) 结果:肠道菌群失调与尿路感染的复发之间存在关联。体重增加与肠道菌群失调有关。此外,对使用抗生素的风险和益生菌的益处缺乏了解与肠道菌群失调和尿路感染的复发有关;(4) 结论:肠道菌群失调可能会影响尿路感染的复发。rUTI 和生活方式领域中肠道菌群失调的风险因素是潜在可控的,为新方法提供了更广阔的视角,并改变了尿路感染的治疗模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/731e/11174854/8eca9ce25f93/nutrients-16-01753-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/731e/11174854/8eca9ce25f93/nutrients-16-01753-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/731e/11174854/8eca9ce25f93/nutrients-16-01753-g001.jpg

相似文献

1
Associations between Gut Microbiota Dysbiosis and Other Risk Factors in Women with a History of Urinary Tract Infections.肠道微生物失调与尿路感染史女性的其他危险因素之间的关联。
Nutrients. 2024 Jun 3;16(11):1753. doi: 10.3390/nu16111753.
2
Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.全科医生提供的标准化中草药治疗与中医师提供的个体化治疗对复发性尿路感染女性的疗效比较:一项随机对照试验的研究方案
Trials. 2016 Jul 27;17:358. doi: 10.1186/s13063-016-1471-5.
3
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.纵向多组学分析将肠道微生物失调与女性复发性尿路感染联系起来。
Nat Microbiol. 2022 May;7(5):630-639. doi: 10.1038/s41564-022-01107-x. Epub 2022 May 2.
4
Recurrent urinary tract infections in women: How promising is the use of probiotics?女性复发性尿路感染:使用益生菌的前景如何?
Indian J Med Microbiol. 2017 Jul-Sep;35(3):347-354. doi: 10.4103/ijmm.IJMM_16_292.
5
Management of uncomplicated recurrent urinary tract infections.单纯性复发性尿路感染的管理。
BJU Int. 2022 Jun;129(6):668-678. doi: 10.1111/bju.15630. Epub 2021 Nov 17.
6
Can the composition of the intestinal microbiota predict the development of urinary tract infections?肠道微生物群的组成能否预测尿路感染的发生?
Future Microbiol. 2016 Oct;11:1395-1404. doi: 10.2217/fmb-2016-0088. Epub 2016 Oct 27.
7
Manipulating the Gut Microbiome in Urinary Tract Infection-Prone Patients.在易患尿路感染的患者中操纵肠道微生物组。
Urol Clin North Am. 2024 Nov;51(4):525-536. doi: 10.1016/j.ucl.2024.07.016.
8
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.大肠杆菌引起复发性尿路感染的重要细菌特征。
Dan Med Bull. 2011 Apr;58(4):B4187.
9
Probiotics for preventing urinary tract infections in adults and children.用于预防成人和儿童尿路感染的益生菌。
Cochrane Database Syst Rev. 2015 Dec 23;2015(12):CD008772. doi: 10.1002/14651858.CD008772.pub2.
10
The etiology and management of recurrent urinary tract infections in postmenopausal women.绝经后女性复发性尿路感染的病因和治疗。
Climacteric. 2019 Jun;22(3):242-249. doi: 10.1080/13697137.2018.1551871. Epub 2019 Jan 9.

引用本文的文献

1
Immunosenescence and the Geriatric Giants: Molecular Insights into Aging and Healthspan.免疫衰老与老年巨擘:衰老与健康寿命的分子见解
Med Sci (Basel). 2025 Jul 28;13(3):100. doi: 10.3390/medsci13030100.
2
Unveiling the microbial orchestra: exploring the role of microbiota in cancer development and treatment.揭开微生物的“管弦乐队”之谜:探索微生物群在癌症发生发展及治疗中的作用。
Discov Oncol. 2025 Apr 30;16(1):646. doi: 10.1007/s12672-025-02352-2.
3
Exploring urinary microbiome: insights into neurogenic bladder and improving management of urinary tract infections.

本文引用的文献

1
Machine learning based assessment of preclinical health questionnaires.基于机器学习的临床前健康问卷评估。
Int J Med Inform. 2023 Dec;180:105248. doi: 10.1016/j.ijmedinf.2023.105248. Epub 2023 Oct 21.
2
Optimizing the Antimicrobial Synergism of Melaleuca alternifolia (Tea Tree) Essential Oil Combinations for Application against Respiratory Related Pathogens.优化互叶白千层(茶树)精油组合对呼吸道相关病原体的抗菌协同作用以用于实际应用。
Planta Med. 2023 Apr;89(4):454-463. doi: 10.1055/a-1947-5680. Epub 2023 Jan 10.
3
Vitamin Supplementation in Pre-Pregnancy and Pregnancy among Women-Effects and Influencing Factors in Romania.
探索尿液微生物群:深入了解神经源性膀胱并改善尿路感染的管理
Front Cell Infect Microbiol. 2025 Apr 1;15:1512891. doi: 10.3389/fcimb.2025.1512891. eCollection 2025.
4
Gut Microbiome Implication and Modulation in the Management of Recurrent Urinary Tract Infection.肠道微生物群在复发性尿路感染管理中的意义及调节
Pathogens. 2024 Nov 21;13(12):1028. doi: 10.3390/pathogens13121028.
5
A Perspective on the Interaction Between Recurrent Lower Urinary Tract Infections and Irritable Bowel Syndrome.关于复发性下尿路感染与肠易激综合征相互作用的观点。
Nutrients. 2024 Oct 24;16(21):3613. doi: 10.3390/nu16213613.
备孕和孕期妇女的维生素补充-罗马尼亚的效果和影响因素。
Int J Environ Res Public Health. 2022 Jul 12;19(14):8503. doi: 10.3390/ijerph19148503.
4
The Community Adaptability to Changes in Rural Romania and the COVID-19 Impact.罗马尼亚农村社区对变化的适应能力和 COVID-19 影响。
Int J Environ Res Public Health. 2021 Oct 11;18(20):10622. doi: 10.3390/ijerph182010622.
5
The Role of Gut, Vaginal, and Urinary Microbiome in Urinary Tract Infections: From Bench to Bedside.肠道、阴道和泌尿微生物群在尿路感染中的作用:从实验室到临床
Diagnostics (Basel). 2020 Dec 22;11(1):7. doi: 10.3390/diagnostics11010007.
6
Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.阿尔茨海默病中的肠道微生物群与生态失调:对发病机制和治疗的影响
Mol Neurobiol. 2020 Dec;57(12):5026-5043. doi: 10.1007/s12035-020-02073-3. Epub 2020 Aug 23.
7
Alternative Therapeutic Options to Antibiotics for the Treatment of Urinary Tract Infections.用于治疗尿路感染的抗生素替代治疗选择
Front Microbiol. 2020 Jul 3;11:1509. doi: 10.3389/fmicb.2020.01509. eCollection 2020.
8
Gut-organ axis: a microbial outreach and networking.肠-器官轴:微生物的扩展与联系
Lett Appl Microbiol. 2021 Jun;72(6):636-668. doi: 10.1111/lam.13333. Epub 2020 Jul 16.
9
The role of the gut microbiome in the development of schizophrenia.肠道微生物群在精神分裂症发展中的作用。
Schizophr Res. 2021 Aug;234:4-23. doi: 10.1016/j.schres.2020.02.010. Epub 2020 Apr 23.
10
Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.尿路感染:微生物发病机制、宿主-病原体相互作用和新的治疗策略。
Nat Rev Microbiol. 2020 Apr;18(4):211-226. doi: 10.1038/s41579-020-0324-0. Epub 2020 Feb 18.